• About Amgen
  • Science
  • Corporate Philanthropy
  • Site Map
  • Search
  • Privacy & Terms
  • Contact Us
Amgen
  • Patients
  • Medical Professionals
  • Partners
  • Investors
  • Careers
  • Media
  • print
  • mail
  • Home
  • Reimbursement Connection®
  • Product Signup

  • Overview
  • Amgen™ Oncology Assistance
  • Aranesp®
    (darbepoetin alfa)
  • Neulasta®
    (pegfilgrastim)
  • NEUPOGEN®
    (Filgrastim)
  • EPOGEN®
    (Epoetin alfa)
  • Sensipar®
    (cinacalcet HCl)
  • Enbrel®
    (etanercept)
  • Kepivance®
    (palifermin)
  • Kineret®
    (anakinra)
  • Vectibix™
    (panitumumab)

Amgen Reimbursement Connection™
Subscribe today to start receiving your Reimbursement updates.

Sign-up for Reimbursement Connection's e-mail service to keep abreast of new information, updates, and features.

Please subscribe by using the form below. You may unsubscribe at any time by using this same form.

To select multiple products, press and hold down the "CTRL" (Mac: Use "Command") key while making your selections.

Required fields are in bold.


First Name:
Last Name:
State:
E-mail Address:
Subscribe:
Unsubscribe:
footer